Your browser doesn't support javascript.
loading
Early therapy improves outcomes of exacerbations of Chronic Obstructive Pulmonary Disease
Wilkinson, Tom M. A; Donaldson, Gavin C; Hurst, John R; Seemungal, Terence A. R; Wedzicha, Jadwiga A.
Afiliação
  • Wilkinson, Tom M. A; St. Bartholomew's Hospital. St. Bartholomew's and the Royal London School of Medicine. Academic Unit of Respiratory Medicine. London. United Kingdom
  • Donaldson, Gavin C; St. Bartholomew's Hospital. St. Bartholomew's and the Royal London School of Medicine. Academic Unit of Respiratory Medicine. London. United Kingdom
  • Hurst, John R; St. Bartholomew's Hospital. St. Bartholomew's and the Royal London School of Medicine. Academic Unit of Respiratory Medicine. London. United Kingdom
  • Seemungal, Terence A. R; St. Bartholomew's Hospital. St. Bartholomew's and the Royal London School of Medicine. Academic Unit of Respiratory Medicine. London. United Kingdom
  • Wedzicha, Jadwiga A; St. Bartholomew's Hospital. St. Bartholomew's and the Royal London School of Medicine. Academic Unit of Respiratory Medicine. London. United Kingdom
Article em En | MedCarib | ID: med-17386
Biblioteca responsável: TT5
Localização: TT5; W1, AM521NF
ABSTRACT
Treatment of chronic obstructive pulmonary disease (COPD) exacerbations improves outcomes; however, responses to treatment are variable, and patients with COPD often delay presentation or fail to seek therapy. The impact on exacerbation outcomes, hospitalization, and health status of delaying or failing to seek treatment is poorly understood. We studied between 1996 and 2002 a cohort of 128 patients with COPD, mean (SD) FEV1 of 1.07 (0.43) L. Patients recorded respiratory symptoms daily and reported exacerbations to the outpatient-based study team or to their primary care physician; 1,099 exacerbations were recorded by the patients, of which 658 were reported to a physician. The time between exacerbation onset and treatment was a median (interquartile range) of 3.69 (2.0–5.57) days, and the exacerbation recovery time was 10.7 (7.0–14.0) days. Earlier treatment was associated with a faster recovery (regression coefficient 0.42 days/day delay) (confidence interval, 0.19–0.65; p < 0.001). Patients who reported a higher proportion of exacerbations for treatment had better health-related quality of life than those patients with more untreated exacerbations (rho = –0.22, p = 0.018). Failure to report exacerbations was associated with an increased risk of emergency hospitalization (rho = 0.21, p = 0.04). Patient recognition of exacerbation symptoms and prompt treatment improves exacerbation recovery, reduces risks of hospitalization, and is associated with a better health-related quality of life
Assuntos
Texto completo: 1 Coleções: 01-internacional Base de dados: MedCarib Assunto principal: Doença Pulmonar Obstrutiva Crônica / Tratamento Farmacológico Aspecto: Patient_preference Limite: Humans Idioma: En Revista: American journal of respiratory and critical care medicine Ano de publicação: 2004 Tipo de documento: Article
Texto completo: 1 Coleções: 01-internacional Base de dados: MedCarib Assunto principal: Doença Pulmonar Obstrutiva Crônica / Tratamento Farmacológico Aspecto: Patient_preference Limite: Humans Idioma: En Revista: American journal of respiratory and critical care medicine Ano de publicação: 2004 Tipo de documento: Article